Search Results

November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc today announced that Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has successfully completed Phase 1 studies in Japan with JNJ-40411813 (ADX71149).

June 2022 "Published on juin 22, 2022 On June 22, 2022, Michel Bouvier, Chief Executive Officer of IRIC

year, Novo Nordisk is strengthening its position in the obesity space through a collaboration with EraCal Under the joint research plan, the Danish giant will work with EraCal to identify novel drug targets Although specific details of the collaboration are yet to be released, EraCal has confirmed that the

Addex Provides Corporate Update And Financial Guidance Structure Therapeutics Appoints Industry Leaders Eric

employed in GPCRs mediated signal transduction.[47] The 2000 Nobel Prize in Physiology or Medicine went to Eric Eric R.

We're sending you all the good vibes and a sprinkle of birthday magic for an epic celebration! 🚀🎉 Kilian Roßmann , Joshua Levitz , Johannes Broichhagen for their excellent work on Deuteration

Previous companies worked at include OrthoBiotech (OBI), a division of Johnson & Johnson and GlaxoSmithKline

A study published in Scientific Data by Arne Hansen et a l has introduced a sensitive method for detecting

Showcases Innovative AI-Driven Drug Design at BRIC AI 2023 Workshop Salipro Biotech AB Celebrates Milestones

ductal adenocarcinoma, β-blockers and antihistamines: A clinical trial is needed Jillian G Baker ,  Erica

Anthony Johnson as President/CEO! Save the dates: February 8 - 29: Join Dr.

interrogation of GPCR co-internalization Kilian Roßmann , Ramona Birke , Joshua Levitz , Ben Jones , Johannes

stability of the salt bridge depends on the position of NH2, which is most stable at position 1 (Wasilko, Johnson

DiMasi JA, Grabowski HG, Hansen RW.